Compare ODC & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ODC | ATEC |
|---|---|---|
| Founded | 1941 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 1994 | 2006 |
| Metric | ODC | ATEC |
|---|---|---|
| Price | $97.59 | $9.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | 98.8K | ★ 2.2M |
| Earning Date | 06-04-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | ★ 50.45 | 15.04 |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $485,572,000.00 | $101,739,000.00 |
| Revenue This Year | N/A | $18.97 |
| Revenue Next Year | N/A | $16.70 |
| P/E Ratio | $58.12 | ★ N/A |
| Revenue Growth | ★ 10.97 | N/A |
| 52 Week Low | $45.61 | $6.82 |
| 52 Week High | $107.00 | $23.29 |
| Indicator | ODC | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 51.18 | 54.88 |
| Support Level | $70.50 | $8.06 |
| Resistance Level | $99.03 | $9.75 |
| Average True Range (ATR) | 3.89 | 0.41 |
| MACD | -0.51 | 0.12 |
| Stochastic Oscillator | 56.53 | 63.87 |
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.